Csl Behring

This study tested an investigational medicine called CSL312 (garadacimab) to see if it could safely prevent painful swelling attacks in children aged 2 to 11 with hereditary angioedema (HAE). The medicine was given as a regular injection to see if it could reduce the number of at…

This study tested the long-term safety and effectiveness of a drug called garadacimab for preventing attacks in people with hereditary angioedema (HAE), a rare genetic condition that causes severe, unpredictable swelling. It involved 171 participants aged 12 and older who had fre…

This was the first study to test a new drug called CSL040 in humans. Researchers gave 62 healthy adults either the drug or a placebo to check for side effects and see how the body processes it. The goal was to gather initial safety data to see if CSL040 could be developed further…

This early-stage study tested how eating food affects the way the body absorbs an experimental drug called vamifeport. It involved 28 healthy adults who took the drug once with food and once without, in a random order. The main goal was to measure the drug levels in the blood und…